Hemabate and Tachypnea - a phase IV clinical study of FDA data

Summary:

Tachypnea is reported as a side effect among people who take Hemabate (carboprost tromethamine), especially for people who are female, 30-39 old, have been taking the drug for < 1 month and have Uterine hypotonus.

The phase IV clinical study analyzes which people have Tachypnea when taking Hemabate. It is created by eHealthMe based on reports of 385 people who have side effects when taking Hemabate from the FDA, and is updated regularly.

What is Hemabate?

Hemabate has active ingredients of carboprost tromethamine. eHealthMe is studying from 387 Hemabate users. Check the latest studies of Hemabate.

What is Tachypnea?

Tachypnea is found to be associated with 1,068 drugs and 1,939 conditions by eHealthMe. Check the latest studies of Tachypnea.



On Jul, 13, 2026

385 people reported to have side effects when taking Hemabate.
Among them, 15 people (3.9%) have Tachypnea.

Could Hemabate cause Tachypnea?

Among these 15 people:

How long have people been on Hemabate when they have Tachypnea? *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Tachypnea when taking Hemabate? *

  • female: 100 %
  • male: 0.0 %

What is the age of people who have Tachypnea when taking Hemabate? *

  • 0-1: 7.69 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 38.46 %
  • 30-39: 53.85 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

What are other side effects people have besides Tachypnea? *

  1. Chest Pain: 8 people, 53.33%
  2. High Blood Pressure: 4 people, 26.67%
  3. Fever: 3 people, 20.00%
  4. Nausea And Vomiting: 3 people, 20.00%
  5. Headache (pain in head): 3 people, 20.00%
  6. Nausea (feeling of having an urge to vomit): 2 people, 13.33%
  7. Cough: 2 people, 13.33%
  8. Wheezing (a high-pitched whistling sound made while you breath): 1 person, 6.67%
  9. Abdominal Pain: 1 person, 6.67%
  10. Agitation (state of anxiety or nervous excitement): 1 person, 6.67%

What are the existing conditions these people have? *

  1. Uterine Hypotonus (inefficient uterine action): 6 people, 40.00%
  2. Postpartum Haemorrhage (bleeding in woman after she has given birth): 4 people, 26.67%
  3. Vaginal Bleeding: 1 person, 6.67%
  4. Uterine Spasm: 1 person, 6.67%
  5. Uterine Contractions Abnormal: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Hemabate and have Tachypnea?

- Check whether Tachypnea is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Hemabate:

Tachypnea treatments and more:

How severe was Tachypnea and when was it recovered:

Expand to all the drugs that have ingredients of carboprost tromethamine:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Hemabate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Tachypnea:

Browse all the conditions that are associated with Tachypnea:


How the study uses the data?

The study uses data from the FDA. It is based on carboprost tromethamine (the active ingredients of Hemabate) and Hemabate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: